Section Arrow
Quote
TNDM.NASDAQ
- Tandem Diabetes Care
Quotes are at least 15-min delayed:2025/01/21 05:35 EST
Last
 35.15
-2.38 (-6.34%)
Day High 
37.84 
Prev. Close
37.53 
1-M High
38.28 
Volume 
1.92M 
Bid
34.02
Ask
35.5
Day Low
34.33 
Open
37.73 
1-M Low
32.46 
Market Cap 
2.46B 
Currency USD 
P/E -- 
%Yield -- 
10-SMA 36.6 
20-SMA 36.16 
50-SMA 33.31 
52-W High 53.69 
52-W Low 21.85 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-1.94/-0.61
Enterprise Value
2.86B
Balance Sheet
Book Value Per Share
3.62
Cash Flow
Cash Flow Yield
0.00
Income Statement
Total Revenue
747.72M
Operating Revenue Per Share
11.75
Industry Comparison
More
Code Name   Last Change Change (%) P/E P/E Range
QSIQuantum-Si2.24-0.3-11.81%-- 
SENSSenseonics Holdings0.8479-0.0271-3.10%-- 
BDMDBaird Medical Investment Holdings Ltd8.85+3.43+63.28%15.32PE
BMRABiomerica0.64-0.066-9.35%-- 
MDTMedtronic plc88.08+0.92+1.06%26.61PE
Quotes are at least 15-min delayed：2025/01/21 05:35 EST
Industry overview quotes are at least 15 minutes delayed
Business Description
Tandem Diabetes designs, manufactures, and markets durable insulin pumps for diabetes patients. The firm first entered this market in 2012 and has since introduced multiple generations of pumps leading to its current t:slim X2 device. The firm recently launched its smaller Mobi pump and continues to work on a tubeless pump. Nearly three-quarters of total revenue is derived from the us, with the remainder primarily from other developed nations. The pumps themselves generate just over half of total sales, and another one third is from disposable infusion sets that need to be changed over every 2 to 3 days.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.